Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies | |
Shigdar, Sarah(Deakin Univ, Sch Med, Waurn Ponds) ; Ward, Alister C.(Deakin Univ, Sch Med, Waurn Ponds) ; De, Abhijit(Tata Mem Hosp, ACTREC) ; Yang, Chaoyong J. ; Yang CY(杨朝勇) ; Wei, Mingqian( Griffith Univ, Sch Med Sci) ; Duan, Wei(Deakin Univ, Sch Med, Waurn Ponds) | |
2011-08-02 | |
关键词 | aptamers nucleic acid-based therapeutics oligonucleotides RNAi targeted therapeutics |
英文摘要 | Haematological malignancies result from a heterogeneous mix of genetic mutations and chromosome aberrations and translocations. Targeted therapies, such as the anti-CD20 antibody rituximab, or the BCR-ABL1 inhibitor imatinib, have proven to be effective treatments in the management of some of these malignancies, though relapsing or refractory disease is still common. Nucleic acid-based therapies have also entered the clinical arena, providing an alternative, complementary approach. The forerunner of these therapies were the antisense oligonucleotides, but their scope has expanded to include short-interfering RNA (siRNA), microRNA, decoy oligonucleotides and aptamers. These can be used either as mono-therapeutics, in conjunction with current chemotherapy regimens, or in combination with each other to improve therapeutic efficacy. Not only can these nucleic acid-based therapies silence target genes, they also have the potential of restoring gene function. While challenges remain in delivering effective doses of nucleic acid in vivo, these are steadily being met, suggesting an optimistic future in the treatment of haematological malignancies. This review summarizes the application of nucleic acid-based therapeutics, particularly aptamers, in the diagnosis and treatment of haematological malignancies.; National Health and Medical Research Council, Australia; Australia-India Strategic Research Fund; Victorian Cancer Agency |
语种 | 英语 |
出版者 | WILEY-BLACKWELL |
内容类型 | 期刊论文 |
源URL | [http://dx.doi.org/doi:10.1111/j.1365-2141.2011.08807.x] ![]() |
专题 | 化学化工-已发表论文 |
推荐引用方式 GB/T 7714 | Shigdar, Sarah,Ward, Alister C.,De, Abhijit,et al. Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies[J],2011. |
APA | Shigdar, Sarah.,Ward, Alister C..,De, Abhijit.,Yang, Chaoyong J..,杨朝勇.,...&Duan, Wei.(2011).Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.. |
MLA | Shigdar, Sarah,et al."Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies".(2011). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论